Complexity in assessing the benefit versus risk of vaccines: experience with rotavirus and dengue virus vaccines

17 October 2019 - The remarkable contribution of immunisation programs to public health is recognised by most people, including those who ...

Read more →

FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

24 September 2019 - The U.S. FDA announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...

Read more →

FDA accepts Merck’s biologics license application and grants priority review for V920, the company’s investigational vaccine for Ebola Zaire virus

17 September 2019 - Merck continues to expand investigational supply to support international Ebola outbreak response. ...

Read more →

FDA reiterates the importance of vaccines such as the Measles, Mumps, and Rubella (MMR) vaccine

6 September 2019 - The U.S. continues to experience cases and outbreaks of measles, largely due to unvaccinated or under-vaccinated segments ...

Read more →

Janssen announces U.S. FDA breakthrough therapy designation for investigational prophylactic vaccine for the prevention of respiratory syncytial virus in older adults

3 September 2019 - Janssen announced today that the U.S. FDA has granted breakthrough therapy designation for the Company's investigational ...

Read more →

Moderna receives FDA fast track designation for Zika vaccine mRNA-1893

19 August 2019 - Moderna today announced that the U.S. FDA has granted fast track designation for its investigational Zika vaccine ...

Read more →

Vas Narasimhan of Novartis: ‘we are not at all prepared for a pandemic’

1 August 2019 - The son of Indian immigrants read Greek philosophy and worked at McKinsey before joining a giant drug ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

First FDA approved vaccine for the prevention of dengue disease in endemic regions

1 May 2019 - The U.S. FDA announced today the approval of Dengvaxia, the first vaccine approved for the prevention of ...

Read more →

Bavarian Nordic announces FDA delay in the review of the biologics license application for MVA-BN smallpox vaccine

11 March 2019 - Bavarian Nordic today announced that it has received information from the U.S. FDA that the review ...

Read more →

Themis Bioscience receives FDA fast track designation for Chikungunya vaccine candidate

25 February 2019 - Themis Bioscience announced today that the United States FDA has granted fast track designation to the ...

Read more →

Merck receives breakthrough therapy designation from FDA for V114, the company’s investigational 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease, in infants, children, and adolescents

30 January 2019 - Merck today announced that V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation ...

Read more →

FDA approves use of 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children as young as 6 months of age

23 January 2019 - The 0.5 mL dose is now approved for use in children 6 months through 35 months of ...

Read more →

FDA approves expanded use of Adacel (Tdap) vaccine for repeat vaccination

14 January 2019 - First and only vaccine approved in the U.S. for repeat vaccination 8 years or more after the ...

Read more →

ImmusanT secures fast track designation for lead therapeutic vaccine candidate Nexvax2 for patients with celiac disease

2 January 2019 - Nexvax2 has been designed to potentially restore immune tolerance to gluten in patients with celiac disease. ...

Read more →